Factors Associated With Weight Gain in People Treated With DolutegravirLucia Taramasso, Antonio Di Biagio, Paolo Bonfanti et al.|Open Forum Infectious Diseases|2020Cited by 70
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational StudyLucia Taramasso, Paolo Maggi, Francesca Vichi et al.|AIDS Patient Care and STDs|2021Cited by 25
Reversibility of Central Nervous System Adverse Events in Course of ArtLucia Taramasso, Paolo Bonfanti, Giancarlo Orofino et al.|Viruses|2022Cited by 14
Real-life safety of Emtricitabine/Tenofovir Alafenamide/BictegravirNicola Squillace, Elena Ricci, Paolo Maggi et al.|PLoS ONE|2023Cited by 14
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA StudyPaolo Bonfanti, Barbara Menzaghi, Giancarlo Orofino et al.|Viruses|2024Cited by 13